Skip to content
2000
Volume 17, Issue 17
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Background: Urinary calculi can be caused by a variety of reasons, such as metabolic abnormalities, urinary tract infection and obstruction. Certain medications can induce urinary stone disease. Ceftriaxone, a third generation cephalosporin with broad spectrum antibiotic activity, primarily eliminated by the kidneys, has now been widely used for treatment of infection. It has been long considered safe, especially in children. However, more and more cases about ceftriaxone induced nephrolithiasis as a rare side effect have been reported. Conclusion: This complication generally resolves spontaneously with cessation of the drug. Severe nephrolithiasis can cause post renal acute renal failure (PARF). There is limited information about how this complication develops, though high doses and extended treatment periods are generally considered to be responsible. Understanding the mechanisms would help the doctors to be aware of this rare complication and respond with proper treatment. The primary goal of this review is to discuss the possible mechanisms based on the most recent literatures.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557516666160801092713
2017-12-01
2025-12-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557516666160801092713
Loading

  • Article Type:
    Research Article
Keyword(s): Ceftriaxone; hydronephrosis; mechanism; nephrolithiasis; urinary tract stones; urolithiasis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test